CompletedNot Applicable

"Clinical Characteristics, Comorbidities and Outcome of Critically Sick Patients With COVID-19

Pakistan133 participantsStarted 2021-03-01

Plain-language summary

COVID-19, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is a multisystem disease which primarily involves the respiratory tract. The first case of COVID-19 was identified in late 2019 in the province of Wuhan, China which was followed by the rapid spread of the disease globally, becoming a present-day pandemic. Objectives: The aim of this study was to describe the clinical characteristics, comorbidities and outcome of the critically sick patients with COVID-19 pneumonia admitted in ICU of a tertiary care hospital in Lahore.

Who can participate

Age range16 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Critically sick patients with COVID-19 Pneumonia * All admitted ICU patients with a diagnosis of COVID-19 pneumonia * Patients having positive reverse transcriptase PCR for COVID-19 * Patients with High-resolution computed tomography (HRCT) chest findings suggestive of COVID-related lung injury * All patients above 16 years of age with both genders( males and females) Exclusion Criteria: * All patients with PCR negative with mild symptoms * Patients with No signs of COVID-19 pneumonia on HRCT chest

What they're measuring

Mortality

Timeframe: 6 months

Trial details

NCT IDNCT05249803

SponsorFMH College of Medicine and Dentistry

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-08-31

View on ClinicalTrials.gov More COVID-19 Pneumonia trials